Ticagrelor Market Research Report: by Dosage (90 MG, 60 MG), by Route of Administration (Oral, Nasogastric Tube), by Application (Acute Coronary Syndrome, Heart Surgeries), by End-user (Hospitals & Clinics, Ambulatory Centers, Others), and Region - Global Forecast till 2027
Market analysis

Ticagrelor is a platelet total inhibitor which blocks the platelets from staying together and prevents blood clusters. It is a medication taken in combination with ibuprofen to forestall heart attacks or strokes in individuals with heart conditions, for example, intense coronary disorder. The developing quantities of the aging masses can likewise goad the market development. The older, who are prone to heart conditions, attributable to their age and low invulnerability levels can give a chance to the market. This is buttressed by the study by United Nations, in which the senior people over the age of 60 had achieved 962 million out of 2017. Be that as it may, the adverse impacts of the medication can be inconvenient to the ticagrelor market development. The global ticagrelor market is expected to reach the value of USD 2,554.39 million by the year 2027 by exhibiting a growth rate of 9% CAGR over the forecast period (2018-2027).

Market segmentation

The global ticagrelor market is segmented on the basis of its dosage, administration, applications, end-users and regional demand. Based on its dosage, the ticagrelor market is divided into two variants, namely 60 Mg and 90 Mg. On the basis of its administration, the market is sectioned into oral and nasogastric tube. Major applications in the ticagrelor market are acute coronary syndrome and heart surgeries. Major end-users of the global ticagrelor market include ambulatory centers,hospitals & clinics, and others.

Regional analysis

Geographically, the global ticagrelor market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

The global ticagrelor market can expand in size owing to the growing incidence of cardiovascular diseases. As per the recent reports by American Heart Association in the year 2014, nearly 31% of deaths in the U.S. were because of the cardiovascular disorders.